GLP-1 receptor agonists and pancreatic safety concerns in type 2 diabetic patients: data from cardiovascular outcome trials.

Chuqing CaoShuting YangZhiguang Zhou

Published in: Endocrine (2020)

Pooled analysis of CVOTs did not suggest any increased risk of either acute pancreatitis or pancreatic cancer with GLP-1RA treatment in T2DM patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
rheumatoid arthritis
adipose tissue
patient reported outcomes
metabolic syndrome
big data
patient reported
insulin resistance